CAS 16320-04-0
:Gestrinone
Description:
Gestrinone is a synthetic steroid with progestational and antiestrogenic properties, primarily used in the treatment of endometriosis and other gynecological disorders. It is classified as a synthetic derivative of testosterone and exhibits a unique mechanism of action by modulating hormonal pathways. Gestrinone functions by inhibiting the secretion of gonadotropins, which in turn reduces estrogen levels, thereby alleviating symptoms associated with estrogen-dependent conditions. The compound is typically administered orally and is characterized by its lipophilic nature, allowing for effective absorption and distribution in the body. Its chemical structure includes a cyclopentene ring, contributing to its biological activity. While Gestrinone is effective in managing certain medical conditions, it may also have side effects, including hormonal imbalances and potential impacts on liver function. As with any medication, its use should be closely monitored by healthcare professionals to ensure safety and efficacy. Overall, Gestrinone represents a significant option in the pharmacological management of specific reproductive health issues.
Formula:C21H24O2
InChI:InChI=1S/C21H24O2/c1-3-20-11-9-17-16-8-6-15(22)13-14(16)5-7-18(17)19(20)10-12-21(20,23)4-2/h2,9,11,13,18-19,23H,3,5-8,10,12H2,1H3/t18-,19+,20+,21+/m1/s1
InChI key:InChIKey=BJJXHLWLUDYTGC-ANULTFPQSA-N
SMILES:C(C)[C@@]12[C@]([C@]3(C(C=C1)=C4C(CC3)=CC(=O)CC4)[H])(CC[C@]2(C#C)O)[H]
Synonyms:- (17α)-13-Ethyl-17-hydroxy-18,19-dinorpregna-4,9,11-trien-20-yn-3-one
- (8S,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,13,14,15,16,17-decahydro-3H-cyclopenta[a]phenanthren-3-one (non-preferred name)
- 13-Ethyl-17-alpha-ethinyl-17-hydroxygon-4,9,11-trien-3-one
- 13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregna-4,9,11-trien-20-yn-3-one
- 13-Ethyl-17α-ethynyl-17β-hydroxygona-4,9,11-trien-3-one
- 13-beta-Ethyl-17-alpha-ethinyl-17-hydroxy-gona-4,9,11-triene-3-one
- 18,19-Dinor-17-alpha-pregna-4,9,11-trien-20-yn-3-one, 13-ethyl-17-hydroxy-
- 18,19-Dinor-17α-pregna-4,9,11-trien-20-yn-3-one, 13-ethyl-17-hydroxy-
- 18,19-Dinorpregna-4,9,11-trien-20-yn-3-one, 13-ethyl-17-hydroxy-, (17-alpha)- (9CI)
- 18,19-Dinorpregna-4,9,11-trien-20-yn-3-one, 13-ethyl-17-hydroxy-, (17α)-
- A 46745
- Brn 5610726
- Dimetriose
- Dimetrose
- Ethylnorgestrienone
- Gestrigone
- Gestrinona
- Gestrinona [INN-Spanish]
- Gestrinone [USAN:INN:BAN]
- Gestrinonum
- Gestrinonum [INN-Latin]
- Nemestran
- Pregna-4,9,11-trien-20-yn-3-one, 13-ethyl-17-hydroxy-18,19-dinor-, (17alpha)-
- R-2323
- Ru 2323
- Tridomose
- Unii-1421533Rcm
- See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 10 products.
Gestrinone
CAS:<p>Gestrinone (R 2323) 是一种合成类固醇激素,能够抑制平滑肌瘤(IC50:43.67 μM),有用于子宫内膜异位症的研究潜力。</p>Formula:C21H24O2Purity:99.21%Color and Shape:Light Yellow SolidMolecular weight:308.41Gestrinone
CAS:Formula:C21H24O2Purity:>98.0%(T)Color and Shape:Light yellow to Yellow powder to crystalMolecular weight:308.42Gestrinone
CAS:Controlled Product<p>Applications Gestrinone is a Steroidal antiestrogen, antiprogestogen, analog of Norgestrienone. Antigonadotropin.Controlled substance.<br>References Azadian-Boulanger, G., et al.: Am. J. Obstet. Gynecol., 125, 1049 (1976), Thomas, E.J., et al.: Br. Med. J., 294, 272 (1987), Coutinho, E.M., et al.: Fertil. Steril., 49, 418 (1988),<br></p>Formula:C21H24O2Color and Shape:NeatMolecular weight:308.406α-Hydroxy Gestrinone Glucuronide
CAS:Controlled ProductFormula:C27H32O9Color and Shape:Light YellowMolecular weight:500.54Gestrinone-d3 (major)
CAS:Controlled ProductFormula:C21D3H21O2Color and Shape:NeatMolecular weight:311.433Gestrinone (1 mg/ml in Acetonitrile)
CAS:Controlled ProductFormula:C21H24O2Color and Shape:Single SolutionMolecular weight:308.40Gestrinone
CAS:Controlled Product<p>Gestrinone is a synthetic steroidal hormone that binds to the progesterone receptor. It has been used in the treatment of endometriosis, although its efficacy is questionable. Gestrinone is a potent inhibitor of cyclooxygenase and lipoxygenase, which leads to an anti-inflammatory effect. Gestrinone also suppresses gonadotropin secretion from the pituitary gland by reducing gonadotropin-releasing hormone (GnRH) release. The drug has been found to have contraceptive activity in vivo and in vitro, but it does not appear to inhibit ovulation or fertilization. Gestrinone inhibits estrogen synthesis by blocking the conversion of estradiol benzoate into estradiol during pregnancy. This drug also inhibits aromatase activity and has been shown to be effective against endometriosis in humans. However, gestrinone is associated with side effects such as nausea, breast tenderness, weight gain, headache, depression and fatigue</p>Formula:C21H24O2Purity:Min. 95%Molecular weight:308.41 g/mol18,19-Dinorpregna-4,9,11-trien-20-yn-3-one, 13-ethyl-17-hydroxy-, (17α)-
CAS:Formula:C21H24O2Purity:99%Color and Shape:SolidMolecular weight:308.4141






